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Background: Evidence suggests that dendritic cells accumulate in the lungs of COPD patients and correlate with
disease severity. We investigated the importance of IL-1R1 and its ligands IL-1α and β to dendritic cell accumulation
and maturation in response to cigarette smoke exposure.
Methods: Mice were exposed to cigarette smoke using a whole body smoke exposure system. IL-1R1-, TLR4-, and
IL-1α-deficient mice, as well as anti-IL-1α and anti-IL-1β blocking antibodies were used to study the importance of
IL-1R1 and TLR4 to dendritic cell accumulation and activation.
Results: Acute and chronic cigarette smoke exposure led to increased frequency of lung dendritic cells.
Accumulation and activation of dendritic cells was IL-1R1/IL-1α dependent, but TLR4- and IL-1β-independent.
Corroborating the cellular data, expression of CCL20, a potent dendritic cells chemoattractant, was IL-1R1/IL-1α-
dependent. Studies using IL-1R1 bone marrow-chimeric mice revealed the importance of IL-1R1 signaling on lung
structural cells for CCL20 expression. Consistent with the importance of dendritic cells in T cell activation, we
observed decreased CD4+ and CD8+ T cell activation in cigarette smoke-exposed IL-1R1-deficient mice.
Conclusion: Our findings convey the importance of IL-1R1/IL-1α to the recruitment and activation of dendritic cells
in response to cigarette smoke exposure.
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The adverse effects of cigarette smoke on human health
are well established [1,2]. Smoking is the leading cause of
chronic obstructive pulmonary disease (COPD), a chronic
lung disorders characterized by progressive and largely
irreversible airflow limitation [3]. It is widely accepted
that chronic inflammation contributes to airflow limitation
observed in COPD; macrophages, neutrophils and T lym-
phocytes are increased in various parts of the lungs [4].
More recently, there is emerging interest in the role of
dendritic cells in COPD [5]. Dendritic cells are highly ef-
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reproduction in any medium, provided the orinnate recognition of foreign antigens, fostering activation
of adaptive immune responses. Evidence suggests that
dendritic cell frequency is increased in the lungs of COPD
patients and that expression of maturation markers corre-
lates with worsening of the disease [6]. Dendritic cells
have been suggested to contribute to lung tissue damage
in smokers through activation of autoreactive T cells
and induction of autoantibody responses [7]. In murine
models, we and others have shown that cigarette smoke
exposure induced the accumulation and maturation of
lung dendritic cells [8,9]. Additionally, dendritic cell
maturation was associated with the development of
emphysema-like lesions [9]. Despite this, mechanisms
underlying the recruitment and maturation of pulmon-
ary dendritic cells remain poorly understood.
IL-1R-type1 (IL-1R1) and its cognate ligands, IL-1α
and β, play a central role in the initiation of inflammatoryl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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logy and mechanisms of intracellular signaling with toll
-like-receptors, key sensors of innate pathogen recogni-
tion. Studies by Doz et al. demonstrated the importance
of IL-1R1, TLR4, and MyD88 (an adaptor signaling mol-
ecule shared by IL-1R1 and TLR4) to cigarette smoke
-induced inflammation [11]; airway neutrophilia was
significantly attenuated in IL-1R1-, TLR4- and MyD88-
deficient mouse strains following cigarette smoke expos-
ure. While increased expression of IL-1α and β was
observed following cigarette smoke exposure, mechanistic
studies revealed that smoke-induced neutrophilic inflam-
mation was IL-1α-dependent, but independent of IL-1β,
and relied on crosstalk between hematopoietic and airway
structural cells [12]. Studies by Churg et al. further
demonstrated that cigarette smoke-induced emphysema
formation was, at least in part, IL-1R1-dependent [13].
The objective of this study was to assess the role of
IL-1R1 and TLR4 in cigarette smoke-induced accumula-
tion and activation of dendritic cells. We show here that
cigarette smoke mediated activation and accumulation
of lung dendritic cells was IL-1R1/IL-1α-dependent
and independent of IL-1β and TLR4 signaling. IL-1R1-
signaling was required in non-hematopoietic lung
structural cells for the expression of the dendritic cell
chemo-attractant and survival factors, CCL20 and
GM-CSF. Finally, CD4+ and CD8+ T cell activation
was IL-1R1-dependent, implicating IL-1-signaling as a




BALB/c mice (6–8 weeks old) were purchased from
Charles River Laboratories (Montreal, Canada). IL-1R1-
and TLR4-deficient mice both on a C57BL/6 back-
ground, as well as, C57BL/6 wild type control animals
(6–8 weeks old) were purchased from Jackson Labora-
tories (Bar Harbor, ME, USA). IL-1α-deficient mice on a
C57BL/6 background [14] were bred in-house. Mice
were maintained under specific pathogen-free conditions
in an access-restricted area, on a 12 h light–dark cycle,
with food and water provided ad libitum. The Animal
Research Ethics Board of McMaster University approved
all experiments.
Cigarette smoke exposure protocol
Mice were exposed to cigarette smoke using a whole
body smoke exposure system (SIU-48, Promech Lab AB
(Vintrie, Sweden)) that was described previously [8].
Mice were exposed to 12 3R4F reference cigarettes with
filters removed (Tobacco and Health Research Institute,
University of Kentucky, Lexington, KY, USA) for a period
of approximately 50 minutes, twice daily, for 4 days(sub-acute exposure), or 5 days/week for 8 weeks
(chronic exposure). Control animals were exposed to
room air only by removing the cage lid and limiting
access to food and water. We previously showed that
expression of the stress hormone corticosterone was
comparable between cigarette smoke and room air-
exposed animals [8].
Generation of IL-1R1-deficient bone marrow chimeric
mice
5 million C57BL/6 wild type or IL-1R1-deficient bone
marrow cells were injected intravenously into irradiated
(2 doses of 550Rads (11Gray total)) recipient C57BL/6
wild type (WT) or IL-1R1-deficient (knockout (KO))
mice. Recipient mice were on trimethoprim and sulfa-
methoxazole antibiotic-treated water one week prior to
irradiation and two weeks following irradiation. Mice
were allowed 8 weeks for reconstitution of hematopoietic
bone marrow cells.
Administration of antibodies
Mice were injected intraperitoneally (i.p.) with 400 μg of
anti-IL-1α (clone ALF161; R&D Systems, Burlington,
Canada), anti-IL-1β (clone B122; R&D Systems), or
Armenian hamster isotype control antibody (Jackson
Immunoresearch, Burlington, Canada) 12 hours prior to
the first smoke exposure, and then daily 1 hour following
the second smoke exposure. Dosing of the antibodies
was based on our previous antibody neutralization stud-
ies [12,15]. Specificity of the antibodies was confirmed by
antibody inhibition assays and reported previously [12].
Isolation of lung mononuclear cells and flow cytometric
analysis
Lung mononuclear cells were isolated as previously
described [8]. Briefly, lungs were perfused with 1x
phosphate-buffered saline (PBS) and cell suspensions
were generated by mechanical mincing and collagenase
digestion. Debris were removed by passage through
nylon mesh and cells were resuspended in 1x PBS con-
taining 0.3% bovine serum albumin (BSA) (Invitrogen,
Burlington, ON, Canada) or in RPMI supplemented with
10% FBS (Sigma-Aldrich, Oakville, ON, Canada), 1%
L-glutamine, and 1% penicillin/streptomycin (Invitrogen,
Burlington, ON, Canada). 1x106 lung mononuclear cells
were washed once with 1x PBS/0.3% BSA and stained
with primary antibodies directly conjugated to fluoro-
chromes for 30 minutes at 4°C. 105 live events were
acquired on an LSR II (BD Biosciences, San Jose, California)
flow cytometer and data analyzed with FlowJo analysis
software (TreeStar Inc., Ashland, Oregon). During flow
cytometric analysis, side scatter and forward scatter
parameters were used to define a live cell gate. All anti-
bodies were purchased from BD Biosciences (San Jose,
Figure 1 (See legend on next page.)
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Figure 1 Cigarette smoke-induced dendritic cell accumulation and maturation is IL-1R1-dependent. C57BL/6 wild type, IL-1R1-, and
TLR4-deficient mice were exposed to cigarette smoke for 4 days. (A) CD45+ whole lung cells were analyzed by flow cytometry for CD11chi major
histocompatibility class (MHC)-IIhi dendritic cells in room air control wild type, and cigarette smoke-exposed wild type, IL-1R1-, and TLR4-deficient
mice. (B) Flow cytometric analysis of CD86+ dendritic cells. Shaded gray histogram represents isotype control stain, while the solid line represents
CD86-positive staining. (C and D) Quantitative analysis of CD45+ CD11chi MHC IIhi dendritic cells (left), CD86+ dendritic cells (CD11chi MHC IIhi)
(middle), and mean fluorescence intensity (M.F.I.) of CD86 on dendritic cells (right) of room air and smoke-exposed wild type (WT; white bar), and
IL-1R1- or TLR4-deficient (gray bar) mice. Fluidigm analysis of CCL20 mRNA expression in IL-1R1-deficient (E) and TLR4-deficient mice (F), and
GM-CSF mRNA expression in TLR4-deficient mice (G). Data presented in A and B are representative of one of five mice from two separate
experiments. C to G represent mean± SEM of at least five mice per group and are representative of at least two independent experiments.
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otherwise stated. The following antibodies were used for
flow cytometric analysis: FITC-conjugated anti-CD11c, PE-
Alexa Fluor 610-conjugated CD8, PE-cy7-conjugated anti-
CD69, APC-conjugated anti-MHC class II, Alexa Fluor
700-conjugated anti-CD86, APC-cy7-conjugated anti-
CD45, and Pacific Blue-conjugated anti-CD3. Qdot605-
conjugated anti-CD4 and Qdot655-conjugated anti-B220
were purchased from Invitrogen (Carlsbad, California).
RNA extraction for fluidigm analysis
RNA was extracted from a single mouse lung lobe. Lung
tissues were collected and placed into 200 μl of RNAlater
(Qiagen, Mississauga, ON, Canada), stored at −80°C until
further use. RNA was extracted using an RNeasy Qiagen
kit (Qiagen, Mississauga, ON, Canada). RNA was quanti-
fied and normalized, and RNA integrity was assessed by
an Agilent Bioanalyzer using the Agilent RNA 6000
Nano Kit (Agilent, Santa Clara, CA, USA). cDNA was
prepared using the Super Script III kit from Life Tech-
nologies according to the manufacturer’s protocol (Life
Technologies, Carlsbard, CA, USA). Relative transcript
expression was assessed by Fluidigm Biomark Dynamic
array.
Statistical analysis
Data were analyzed using IBM SPSS Statistics version 18.0
Software (Chicago, Illinois) and expressed as means±
standard errors of the means (SEM). We assessed signifi-
cance (p< 0.05) using the SPSS Univariate General Linear
Model and one- or two-way analysis of variance (ANOVA)
was followed by multiple t-tests.Table 1 Frequency of B220+ CD11c+ plasmacytoid
dendritic cells in cigarette smoke-exposed mice
Room air [%] Cigarette smoke [%] P value
WT 0.070± 0.014 0.200 ± 0.001 <0.0001
IL-1R1KO 0.080± 0.012 0.220 ± 0.044 0.0001
TLR4KO 0.325± 0.126 0.360 ± 0.054 0.5891
Four-day room air and cigarette smoke-exposed C57BL/6 wild type (WT),
IL-1R1-knockout (KO) and/or TLR4KO mouse whole lung tissue were analyzed,
by flow cytometry, for the percentage of B220+/CD11c+ plasmacytoid dendritic
cells. Data are presented as mean +/− standard deviation (SD).Results
Accumulation and activation of lung dendritic cells in
response to cigarette smoke exposure is IL-1R1-
dependent and TLR4-independent
Recent studies by Doz et al. have highlighted the import-
ance of IL-1R1 and TLR4 in cigarette smoke-induced
lung neutrophilia [11]. Here, we assessed the relative
importance of IL-1R1 and TLR4 signaling to dendritic
cell accumulation and activation following cigarettesmoke exposure. C57BL/6 wild type, IL-1R1-, and TLR4-
deficient mice were exposed to room air or cigarette
smoke for 4 days. Under these experimental conditions,
we previously reported that neutrophilia was significantly
attenuated in IL-1R1 deficient animals compared to wild-
type controls [12]. Similarly, we observed attenuated
neutrophilia in TLR4-deficient mice (data not shown).
We observed an increase in CD11chigh/MHC IIhigh lung
myeloid dendritic cells in cigarette smoke-exposed
C57BL/6 wild type mice compared to room air controls
(Figures 1A). Moreover, smoke exposure led to increased
expression of CD86 (B7-2), a dendritic cell activation
marker and co-stimulatory molecule (Figure 1B). Lung
myeloid dendritic cells and expression of CD86 were sig-
nificantly decreased in cigarette smoke-exposed IL-1R1-
deficient mice compared to wild type controls (Figure 1A
and C). In contrast, cigarette smoke exposure led to
accumulation of myeloid dendritic cells and increased
expression of CD86 in TLR4-deficient mice (Figure 1A
and D). These findings suggest an accumulation and acti-
vation of myeloid dendritic cells in response to cigarette
smoke exposure that is IL-1R1-dependent and redundant
of TLR4.
As previously reported in BALB/c mice, we observed
an increase in CD11c+/B220+ plasmacytoid dendritic
cells in C57BL/6 mice following cigarette smoke exposure
(Table 1) [15]. A similar increase in plasmacytoid dendritic
cells was observed between cigarette smoke-exposed
C57BL/6 wild type and IL-1R1 deficient mice (Table 1).
Collectively, these data suggest that cigarette smoke-
induced accumulation and activation of lung myeloid but
not plasmacytoid dendritic cells is IL-1R1-dependent and
TLR4-independent.
Figure 2 Cigarette smoke-induced increases in lung dendritic cells, CCL20 and GM-CSF expression is IL-1α-dependent. (A) BALB/c were
exposed to cigarette smoke for 4 days. Hamster IgG isotype control (white bar), anti-IL-1α (gray bar), or anti-IL-1β (black bar) antibody were
injected intraperitoneally daily starting one day prior to room air or smoke exposure. Data show flow cytometric analysis of CD11chi MHC IIhi
dendritic cells (left) and expression of CD86 (right) (M.F.I., mean fluorescence intensity). (B) Dendritic cell frequency and expression of CD86 was
examined in smoke-exposed IL-1α-deficient (gray bar) and wild type (white bar) mice. (C) Expression of CCL20 (left) and GM-CSF (right) in 4-day
smoke-exposed mice injected with hamster isotype control, anti-IL-1α or anti-IL-1β antibodies. Data are presented as the mean± SEM of at least
five mice per group and are representative of at least two independent experiments.
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factors is IL-1R1-dependent
Next, we investigated whether IL-1R1 signaling was
required for the expression of dendritic cell chemo-
attractant and survival factors. We focused our analysis
on CCL-20 based on previous reports that CCR6, the re-
ceptor for CCL20, is critically required for dendritic cell
accumulation in response to cigarette smoke [9]. Consist-
ent with changes observed in lung dendritic cell frequency,
robust up-regulation of CCL20 was observed in wild-type
mice, while CCL20 expression was not increased in
IL-1R1-deficient mice (Figure 1E). In agreement with the
cellular data, we observed a similar induction of CCL20in cigarette smoke-exposed TLR4-deficient and wild type
mice (Figure 1F). As previously reported, cigarette smoke
exposure was associated with a significant increase in
GM-CSF expression (Figure 1G) [15], a known dendritic
cell survival and maturation factor [16]. We observed a
modest decrease in GM-CSF expression in TLR4-
deficient compared to wild type mice, contrasting our
previous observations that cigarette smoke-induced ex-
pression of GM-CSF was abrogated in IL-1R1 knock-
out mice [15]. These data suggest that IL-1R1, but
not TLR4 is critically required for the expression of
key dendritic cell survival and chemotactic factors in
response to cigarette smoke exposure.
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IL-1 exists as two isoforms, IL-1α and IL-1β, both of
which signal through the IL-1R1. We previously reported
increased expression of both ligands in response to
cigarette smoke exposure [12]. We next examined
whether accumulation and activation of dendritic cells in
response to cigarette smoke exposure was IL-1α and/or
IL-1β-dependent. BALB/c mice were exposed to cigarette
smoke for 4 days. Anti-IL-1α or anti-IL-1β blocking anti-
body, or an isotype control antibody were delivered daily
to cigarette smoke-exposed mice. Anti-IL-1α, but not
anti-IL-1β, significantly attenuated dendritic cell fre-
quency and maturation (as assessed by CD86 expression)
(Figure 2A). Similarly, we previously reported that
cigarette smoke-induced neutrophilia was IL-1α, but not
IL-1β-dependent [12].
To corroborate the observation that dendritic cell ac-
cumulation was IL-1α-dependent, we exposed wild type
C57BL/6 and IL-1α-deficient mice to room air or
cigarette smoke for 4 days. Consistent with the antibody
neutralization studies, IL-1α was critically required for
dendritic cell accumulation in response to cigarette
smoke exposure (Figure 2B). Of note, CD86 expression
was not altered in the absence of IL-1α (Figure 2B). In
agreement with the cellular data, we observed attenuated
expression of CCL20 and GM-CSF in cigarette smoke-
exposed mice treated with anti-IL-1α, but not anti-IL-1β
antibodies (Figure 2C). Thus, the IL-1R1 ligand IL-1α,
but not IL-1β, is necessary for cigarette smoke-induced
dendritic cell accumulation in the mouse lung.Dendritic cell accumulation following chronic smoke
exposure is IL-1R1/IL-1α dependent
The studies pursued thus far focused on dendritic cell
accumulation and maturation in response to subchronic
cigarette smoke exposure. We next investigated whether
dendritic cell accumulation observed following chronicFigure 3 Increases in lung dendritic cells following chronic cigarette s
IL-1R1- (A), and IL-1α-deficient (B) mice were exposed to cigarette smoke fo
dendritic cells by flow cytometry. Results are presented as mean± SEM of a
two independent experiments.cigarette smoke exposure was similarly IL-1R1/IL-1α
dependent. To this end, C57BL/6 wild type, IL-1R1-, and
IL-1α-deficient mice were exposed to cigarette smoke for
8 weeks. As seen in Figure 3A, chronic cigarette smoke
exposure induced a significant increase in the frequency
of lung dendritic cells. The magnitude of dendritic cell
accumulation was comparable between acute and chronic
cigarette smoke exposure. In accordance with our findings
after acute cigarette smoke exposure, IL-1R1-, and IL-1α-
deficiency attenuated the accumulation of lung dendritic
cells (Figure 3A and B).IL-1R1 expression is necessary on non-haematopoeitic
structural cells for expression of CCL20 and GM-CSF
Next, we assessed the importance of IL-1R1 expression
on haematopoeitic and non-haematopoetic cells for the
production of CCL20 and GM-CSF. This study was
based on our previous observations that crosstalk be-
tween IL-1α+ hematopoietic cells and the IL-1R1+
epithelial cells regulates smoke-induced neutrophilia [12].
Significantly increased expression of CCL20 and GM-CSF
was observed in cigarette smoke-exposed mice following
transfer of C57BL/6 wild type bone marrow (WT) into
irradiated (to deplete haematopoetic cells) wild type mice
(WT!WT) (positive control) (Figure 4A and B). No
increase in CCL20 and GM-CSF expression was observed
in irradiated IL-1R1-deficient recipients reconstituted with
IL-1R1-deficient bone marrow (KO) into (KO!KO)
(negative control), as well as, IL-1R1-deficient mice that
were reconstituted with bone marrow from C57BL/6
wild type mice (WT!KO). Bone marrow chimeric
mice generated by the transfer of IL-1R1-deficient bone
marrow into C57BL/6 wild type irradiated recipient
mice (KO!WT) showed increased expression of GM-
CSF and CCL20 in response to cigarette smoke expos-
ure. While GM-CSF expression in KO!WT was com-
parable to WT!WT chimeric mice, we observed a
partial reduction in CCL20 expression. Taken together,moke exposure is IL-1R1/IL-1α-dependent. C57BL/6 wild type,
r 8 weeks. Whole lung cells were analyzed for CD45+ CD11chi MHC IIhi
t least five mice per group. Data shown are representative of at least
Figure 4 Expression of IL-1R1 on non-haematopoetic cells is necessary for smoke-induced expression of CCL20 and GM-CSF. Chimeric
mice were generated as follows, WT to WT: C57BL/6 wild type bone marrow transferred into irradiated C57BL/6 wild type mice; KO to KO:
IL-1R1-deficient bone marrow transferred into irradiated IL-1R1-deficient mice; KO to WT: IL-1R1-deficient bone marrow transferred into irradiated
C57BL/6 wild type mice; WT to KO: C57BL/6 wild type bone marrow transferred into irradiated IL-1R1-deficient mice. Chimeric mice were exposed
to cigarette smoke for 4 days. Expression of CCL20 and GM-CSF mRNA was assessed by fluidigm analysis. Results are presented as mean± SEM of
at least five mice per group. Data are representative of at least two independent experiments.
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haematopoeitic structural cells is necessary for cigarette
smoke-induced expression of CCL20 and GM-CSF.
Cigarette smoke-induced expansion of activated T cells is
IL-1R1/ IL-1α dependent
Dendritic cells are essential for initiating potent T cell
responses [17] and we previously observed T cell activa-
tion following exposure to cigarette smoke [8]. We there-
fore assessed whether IL-1R1 and IL-1α are required for
the expansion of activated T cells in response to cigarette
smoke exposure. C57BL/6 wild type, IL-1R1-, and IL-1α-
deficient mice were exposed to cigarette smoke for 4 days.
Cigarette smoke exposure significantly increased the fre-
quency of lung CD4 and CD8 T cells expressing the acti-
vation marker CD69 (Figure 5). Expansion of activated
CD4 T cells was attenuated in cigarette smoke-exposed
IL-1R1- and IL-1α-deficient mice. Of note, attenuation of
CD8 T cells activation was only observed in IL-1R1-
deficient mice, while IL-1α deficiency did not impact
CD8 T cell activation. Interestingly, in contrast to IL-1R1-
and IL-1α-deficient mice, smoke-exposed TLR4-deficient
mice showed an increased frequency of CD69+ CD4+
and CD8+ T cells. Thus, consistent with decreased den-
dritic cell frequency and maturation, activation of CD4 T
cells is IL-1R1-dependent.
Discussion
Several investigations of mechanisms mediating cigarette
smoke-induced inflammation have implicated IL-1R1/
TLR-4 signaling [11,13], a canonical inflammatory sig-
naling pathway central to innate immune processes [10].
In the present study, we investigate the influence of
these signaling pathways on dendritic cell accumulation
in response to cigarette smoke.
COPD is characterized by a complex immunopathology
involving innate and adaptive immune cells [3,18].
Neutrophils and macrophages are thought to be themajor participants at early stages of the disease, releasing
damaging proteolytic enzymes, while emerging evidence
suggest that autoimmune processes may contribute to
sustained inflammation at later stages of the disease [19].
Although mechanisms mediating autoimmune processes
in COPD remain unclear, dendritic cells are of notable
interest. Dendritic cells are pivotal in the induction of
adaptive immune responses and link innate and adaptive
immunity [20]. Of note, dendritic cells accumulate in the
lungs of COPD patients, and we and others have shown
lung dendritic cells to expand and become activated in
murine models of cigarette smoke exposure [8,9].
Utilizing IL-1R1- and TLR4-deficient mice, we show
that smoke-induced accumulation and activation of lung
dendritic cells is IL-1R1-dependent, but redundant of
TLR4 signaling. In contrast, we observed a similar in-
crease in the proportion of lung plasmacytoid dendritic
cells in wild type and IL-1R1 deficient mice in response
to cigarette smoke-exposure. This finding is in agreement
with our previous observations that intervention with an
anti-GM-CSF antibody did not affect accumulation of
plasmacytoid dendritic cells [15]. While cigarette smoke
has been shown to contain biologically relevant levels of
the TLR4 ligand LPS [21], our findings demonstrate that
LPS contamination does not contribute to dendritic cell
accumulation in the lungs. In agreement with our obser-
vations, Maes et al. reported TLR4-independent den-
dritic cell expansion and maturation after prolonged
smoke exposure, although a reduction was observed at
earlier time points (5 weeks) [22]. Mechanisms that con-
tributed to this transient TLR4 dependency were not
addressed by Maes et al. [22]. Differences between our
studies may relate to the genetic background of the mice,
as variation in susceptibility of mouse strains to cigarette
smoke has previously been reported [23,24]. Alterna-
tively, differences in smoke exposure systems utilized be-
tween the two studies may account for the observed
disparity in the TLR4 dependency.
Figure 5 Cigarette smoke-induced activation of CD4 T cells is IL-1R1/IL-1α-dependent. C57BL/6 wild type control and IL-1R1- (A), IL-1α- (B)
and TLR4-deficient mice (C) were exposed to room air or cigarette smoke for 4 days. Data show flow cytometric analysis of lung CD69+ CD4+ T
cells (CD3+ cells) (left panels) and CD69+ CD8+ T cells (right panels). Results are presented as mean± SEM of at least five mice per group. Data are
representative of at least two independent experiments.
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expression of IL-1α and IL-1β [12]. Both cytokines signal
through IL-1R1 [10], and may contribute to dendritic
cell accumulation in response to cigarette smoke. Anti-
IL-1α antibodies and IL-1α-deficiency, but not anti-
IL-1β antibodies, reduced smoke-induced dendritic cell
accumulation. Despite decreased accumulation of den-
dritic cells, we observed increased expression of the activa-
tion marker CD86 in IL-1α-deficient mice. This finding
contrasts our observations using anti-IL-1α antibodies;
administration of anti-IL-1α antibodies attenuated both
accumulation and activation of dendritic cells. Differ-
ences in phenotype between the gene knockout studies
and antibody intervention may be explained by the
strain’s adaptation to the IL-1α deficiency. Nevertheless,
we demonstrate for the first time an IL-1α-dependent and
IL-1β-independent mechanism by which cigarette smoke
regulates dendritic cell expansion. Similarly, we recently
reported that smoke-driven neutrophilic inflammation is
IL-1α/IL-1R1-dependent and redundant of IL-1β [12].
Our findings contrast observations by Churg et al.
reporting that smoke-induced neutrophilia was IL-1βdependent [13]. This study was pursued using pharmaco-
logical inhibitors of caspase-1 to block processing and
maturation of bioactive IL-1β and a single acute exposure
to whole smoke from 3 cigarettes. Hence, differences in
the experimental approach may account for the differen-
tial requirement for IL-1α and IL-1β. Moreover, Churg
et al. did not assess the impact of caspase-1 inhibitors on
dendritic cell expansion, precluding a direct comparison
to our observations. Given that both IL-1α and IL-1β are
expressed in COPD and during episodes of acute exacer-
bation [12], therapies targeted at the receptor rather than
the individual ligands may be more relevant for limiting
inflammation and exacerbations in COPD.
Mechanisms that contribute to IL-1α expression in
response to cigarette smoke exposure are the subject of
active investigation. It is currently not understood
whether components of cigarette smoke directly activate
IL-1α expression or whether danger associated molecular
patterns (DAMPs) that are released secondary to cigarette
smoke-induced cell death lead to IL-1α expression; as
there is compelling evidence that cigarette smoke ex-
posure induces both apoptotic and necrotic cell death
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has been shown to be elevated in COPD airways [28],
and may induce along with other DAMPs IL-1α ex-
pression. Alternatively, IL-1alpha may be directly released
from dying cells and serve as an alarmin. Further ana-
lysis of these pathways is warranted, as these mechan-
isms may provide rationale for the design of novel
pharmacotherapies.
CCL20 is one of the most potent dendritic cell
chemoattractants [29]. CCL20 expression is increased in
the airways of COPD patients [30], and expression of its
receptor, CCR6, is critical for the recruitment of den-
dritic cells to the lungs of smoke-exposed mice [9].
Mirroring the accumulation of dendritic cells, CCL20
expression was IL-1R1-dependent and TLR4-independent.
Mechanistically, we show using bone marrow chimeric
mice that IL-1R1 expression on structural cells was
required for smoke-induced CCL20 expression. Given
that hematopoietic cells predominantly express IL-1α in
mice exposed to cigarette smoke [12], our findings sug-
gest that crosstalk between IL-1α+ hematopoietic cells
and the IL-1R1+ epithelial cells underlies CCL20 expres-
sion and dendritic cell recruitment.
In addition to recruitment, increased expression of
dendritic cell survival factors may also contribute to
dendritic cell expansion in response to cigarette smoke
exposure. We previously reported that GM-CSF, a den-
dritic cell survival and maturation factor, is upregulated
following cigarette smoke exposure and that administra-
tion of GM-CSF ligand or receptor neutralizing antibodies
attenuated smoke-induced lung dendritic cell expansion
[15]. Hence, attenuated GM-CSF expression in IL-1R1-
deficient mice may contribute to decreased dendritic
cell survival. However, TLR4-deficient mice, in which we
did not observe attenuated dendritic cell accumulation,
showed a modest, yet statistically significant, reduction in
GM-CSF expression. These findings suggest that GM-
CSF-mediated dendritic cell survival may only partially
account for dendritic cell accumulation.
Dendritic cells efficiently present antigens and express
costimulatory molecules that engage and activate T cells
and, therefore, orchestrate the development of productive
adaptive immune responses [17]. Both IL-1 and TLR4
signaling have been implicated in regulating dendritic
cell function, and consequently, shaping T cell-mediated
immunity [10]. Of note, components of cigarette smoke
have been demonstrated to have suppressive and/or
activating activity on immune cells [31,32]. For instance,
nicotine in cigarette smoke has been shown to stimulate
dendritic cell function, yet, suppress T cell activation
[32,33]. More recently, we and others have shown that
cigarette smoke activates dendritic cells and T cells in the
mouse lung. Consistent with our dendritic cell findings,
we show smoke-driven CD4+ T cell activation to beIL-1α- and IL-1R1-dependent and TLR4-independent.
Attenuation of CD8+ T cell activation was only observed
in IL-1R1-, but not in IL-1alpha deficient mice. This may
point towards a differential regulation of CD4+ and
CD8+ T cell activation in response to cigarette smoke
exposure. Future experimentation, however, is required
to solidify this interpretation. Interestingly, we observed
increased CD4+ and CD8+ T cell activation in TLR4-
deficient mice in response to cigarette smoke, consistent
with the finding that TLR4 can function as a negative
regulator in lung inflammatory processes [34]. Thus, we
propose that IL-1α-dependent and TLR4-independent
smoke-driven dendritic cell expansion and maturation
mediates subsequent activation of lung resident T cell.
The latter is of particular interest as emerging literature
suggest that inflammatory processes mediated by T cells
may persists for years after smoking cessation [35,36].
While the specificity of this T cell response remains to be
elucidated, there is active discussion whether persistent
activation of dendritic cells triggers autoimmune pro-
cesses in smokers, contributing to the pathogenesis of
COPD [19].
Conclusions
Our study reveals the significance of IL-1α and its
receptor, IL-1R1, to cigarette smoke-induced accumu-
lation and maturation of lung dendritic cells. We show
this process to be independent of TLR4-signaling and
IL-1β-mediated mechanisms. Taken together, these data
support the targeting of IL-1α/IL-1R1 and dendritic cell
function as a strategy for managing smoke-induced in-
flammation and processes underlying the pathogenesis of
COPD.
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